Covid-19 vaccines do not cause significant metabolic changes, easing concerns about potential long-term side effects, ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

In addition, HHS Secretary Robert F. Kennedy Jr. addressed the delay in Novavax's approval in a CBS interview earlier this ...

Colleges that require students to undergo a COVID-19 vaccine will have their federal funding ended if House lawmakers get their way following a President Donald Trump executive order.

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

RiverStone Health encourages everyone to receive the updated COVID-19 vaccine as recommended by the Centers for Disease ...

Yahoo Finance host Julie Hyman takes a look at today's top moving stocks and biggest market stories in this segment of Market ...

The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...

Blue Cross Blue Shield of Michigan resolved a lawsuit filed by a woman who said she was fired for refusing to get a Covid-19 ...